We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
iCAD announced that it received a letter from R2 Technology, the company's principal
competitor, advising the company of R2's position that iCAD's Second Look product
lines allegedly infringed on US Patents 6,266,435, 6,477,262 and 6,574,357,
which are licensed to R2.
Dade Behring announced its 510(k) submission to the FDA for a Class I device
classification for the Dimension Vista 1500 System, the company's first integrated
chemistry/immunochemistry system targeted at high-volume clinical laboratory
customers.
Inverness Medical Innovations, a manufacturer and
marketer of rapid diagnostic products for the consumer and professional markets,
and Quidel, a provider of point-of-care rapid diagnostic tests, announced they
have entered into a settlement agreement terminating all domestic and international
intellectual property litigation between them.
Medicare will pay for ultrasound treatments to help mend broken bones in any
beneficiary whose fractures won't heal, not just patients who have undergone
failed surgery, the agency said.
Boston Scientific has announced one-year data from its carotid artery stenting
(CAS) clinical trial known as BEACH, evaluating the effectiveness of stenting
with embolic protection for patients who are at high-risk for carotid endarterectomy
(CEA), the surgical treatment for carotid artery disease.
SpinalMotion, a developer of advanced total artificial disc technology for treating
patients with degenerative disc disease, has received conditional approvals
from the FDA for two investigational device exemption (IDE) applications.
Shareholders of medical devicemaker Guidant voted overwhelmingly in favor of
Johnson & Johnson's (J&J) planned $25.4 billion acquisition of the Indianapolis-based
company.
A committee of state finance ministers in India decided to fix the Vat rate
for medical equipment and devices under a specified list at 4 percent, instead
of the peak rate of 12.5 percent.
Merge Technologies, doing business as Merge eFilm, announced an expanded contract
with Radiologix, a national provider of diagnostic imaging services, for the
purchase of FUSION RIS/PACS for its operations in the San Francisco Bay area.